Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 2.50 (1.33%)
Spread: 10.00 (5.405%)
Open: 187.50
High: 190.00
Low: 187.50
Prev. Close: 187.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Oct 2015 10:35

RNS Number : 2421D
Synectics PLC
23 October 2015
 

 

23 October 2015

 

 

 

Synectics plc

(the "Company")

Director/PDMR shareholding

 

The Company has been notified that the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") has purchased 9,400 ordinary shares of 20 pence each in the Company in accordance with the ESAP's rules and on behalf of all ESAP participants.

The shares were purchased on 22 October 2015 at a price of 168 pence each in respect of the six month accumulation period ended on 30 September 2015.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares in the Company at the end of the six month contribution period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period (123.5 pence).

As a result of these purchases, the Company has been notified that Paul Webb and Nigel Poultney, directors of the Company, have acquired an interest in 607 shares and 729 shares respectively and Mike Stilwell, Finance Director (Designate), has acquired an interest in 729 shares.

Following the share purchase in relation to the ESAP, the interests of Paul Webb, Nigel Poultney and Mike Stilwell in Synectics shares are as follows:

 

Name

Position

Beneficial Interest

Interest in Share Schemes

ResultantTotalInterest

% ofIssuedShare Capital

Paul Webb

Chief Executive

0

268,883

268,883

1.51%

Nigel Poultney

Finance Director

13,000

259,145

272,145

1.53%

Mike Stilwell *

Finance Director (designate)

2,910

33,574

36,484

0.21%

* appointment to the Board effective on 1 December 2015

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850080

Richard Brierley, Deputy Company Secretary

legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Westhouse Securities Limited

Tel: +44 (0) 207 601 6100

Tom Griffiths

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEANEDADASFEF
Date   Source Headline
24th Apr 202410:00 amRNSResult of AGM
24th Apr 20247:00 amRNSAGM Statement
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.